Quark Pharmaceuticals Inc - Product Pipeline Review

Global Markets Direct’s, ‘Quark Pharmaceuticals Inc - Product Pipeline Review - 2016’, provides an overview of the Quark Pharmaceuticals Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Quark Pharmaceuticals Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Quark Pharmaceuticals Inc

The report provides overview of Quark Pharmaceuticals Inc including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Quark Pharmaceuticals Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Quark Pharmaceuticals Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Quark Pharmaceuticals Inc’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Quark Pharmaceuticals Inc

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Quark Pharmaceuticals Inc’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Quark Pharmaceuticals ...

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Quark Pharmaceuticals Inc Snapshot 7

Quark Pharmaceuticals Inc Overview 7

Key Facts 7

Quark Pharmaceuticals Inc - Research and Development Overview 8

Key Therapeutic Areas 8

Quark Pharmaceuticals Inc - Pipeline Review 11

Pipeline Products by Stage of Development 11

Pipeline Products - Monotherapy 12

Pipeline Products - Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Pipeline Products - Out-Licensed Products 15

Out-Licensed Products/Combination Treatment Modalities 16

Quark Pharmaceuticals Inc - Pipeline Products Glance 17

Quark Pharmaceuticals Inc - Late Stage Pipeline Products 17

Phase III Products/Combination Treatment Modalities 17

Quark Pharmaceuticals Inc - Clinical Stage Pipeline Products 18

Phase II Products/Combination Treatment Modalities 18

Quark Pharmaceuticals Inc - Early Stage Pipeline Products 19

Preclinical Products/Combination Treatment Modalities 19

Discovery Products/Combination Treatment Modalities 20

Quark Pharmaceuticals Inc - Drug Profiles 21

QPAL-1 - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

QPAL-2 - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

QPCO-1 - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

QPCP-1 - Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

QPEN-1 - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

QPEN-2 - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

QPHL-1 - Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

QPHL-2 - Drug Profile 29

Product Description 29

Mechanism Of Action 29

R&D Progress 29

QPHL-3 - Drug Profile 30

Product Description 30

Mechanism Of Action 30

R&D Progress 30

QPI-1002 - Drug Profile 31

Product Description 31

Mechanism Of Action 31

R&D Progress 31

QPI-1007 - Drug Profile 35

Product Description 35

Mechanism Of Action 35

R&D Progress 35

QPI-1024 - Drug Profile 38

Product Description 38

Mechanism Of Action 38

R&D Progress 38

QPLI-1 - Drug Profile 39

Product Description 39

Mechanism Of Action 39

R&D Progress 39

QPLI-2 - Drug Profile 40

Product Description 40

Mechanism Of Action 40

R&D Progress 40

QPNR-1 - Drug Profile 41

Product Description 41

Mechanism Of Action 41

R&D Progress 41

Quark Pharmaceuticals Inc - Pipeline Analysis 42

Quark Pharmaceuticals Inc - Pipeline Products by Target 42

Quark Pharmaceuticals Inc - Pipeline Products by Route of Administration 43

Quark Pharmaceuticals Inc - Pipeline Products by Molecule Type 44

Quark Pharmaceuticals Inc - Pipeline Products by Mechanism of Action 45

Quark Pharmaceuticals Inc - Dormant Projects 46

Quark Pharmaceuticals Inc - Locations And Subsidiaries 47

Head Office 47

Appendix 48

Methodology 48

Coverage 48

Secondary Research 48

Primary Research 48

Expert Panel Validation 48

Contact Us 48

Disclaimer 49

List of Tables

List of Tables

Quark Pharmaceuticals Inc, Key Facts 7

Quark Pharmaceuticals Inc - Pipeline by Indication, 2016 9

Quark Pharmaceuticals Inc - Pipeline by Stage ...

List of Tables

Quark Pharmaceuticals Inc, Key Facts 7

Quark Pharmaceuticals Inc - Pipeline by Indication, 2016 9

Quark Pharmaceuticals Inc - Pipeline by Stage of Development, 2016 11

Quark Pharmaceuticals Inc - Monotherapy Products in Pipeline, 2016 12

Quark Pharmaceuticals Inc - Partnered Products in Pipeline, 2016 13

Quark Pharmaceuticals Inc - Partnered Products/ Combination Treatment Modalities, 2016 14

Quark Pharmaceuticals Inc - Out-Licensed Products in Pipeline, 2016 15

Quark Pharmaceuticals Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016 16

Quark Pharmaceuticals Inc - Phase III, 2016 17

Quark Pharmaceuticals Inc - Phase II, 2016 18

Quark Pharmaceuticals Inc - Preclinical, 2016 19

Quark Pharmaceuticals Inc - Discovery, 2016 20

Quark Pharmaceuticals Inc - Pipeline by Target, 2016 42

Quark Pharmaceuticals Inc - Pipeline by Route of Administration, 2016 43

Quark Pharmaceuticals Inc - Pipeline by Molecule Type, 2016 44

Quark Pharmaceuticals Inc - Pipeline Products by Mechanism of Action, 2016 45

Quark Pharmaceuticals Inc - Dormant Developmental Projects,2016 46

List of Figures

List of Figures

Quark Pharmaceuticals Inc - Pipeline by Top 10 Indication, 2016 9

Quark Pharmaceuticals Inc - Pipeline by Stage of Development, 2016 11 ...

List of Figures

Quark Pharmaceuticals Inc - Pipeline by Top 10 Indication, 2016 9

Quark Pharmaceuticals Inc - Pipeline by Stage of Development, 2016 11

Quark Pharmaceuticals Inc - Monotherapy Products in Pipeline, 2016 12

Quark Pharmaceuticals Inc - Partnered Products in Pipeline, 2016 13

Quark Pharmaceuticals Inc - Pipeline by Target, 2016 42

Quark Pharmaceuticals Inc - Pipeline by Route of Administration, 2016 43

Quark Pharmaceuticals Inc - Pipeline by Top 10 Molecule Type, 2016 44

Quark Pharmaceuticals Inc - Pipeline Products by Mechanism of Action, 2016 45

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports